Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002173.SZ Stock Summary
Top 10 Correlated ETFs
002173.SZ
In the News
002173.SZ Financial details
Company Rating
Sell
Market Cap
4.26B
Income
-74.9M
Revenue
776.29M
Book val./share
4.28
Cash/share
1.33
Dividend
-
Dividend %
-
Employees
2.63K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
-47.1
Forward P/E
-
PEG
18.74
P/S
4.64
P/B
1.87
P/C
6.57
P/FCF
-22.66
Quick Ratio
2.18
Current Ratio
2.43
Debt / Equity
0.03
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.17
EPS next Y
-
EPS next Q
-
EPS this Y
-26.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-7.69%
Revenue Q/Q
0.36%
EPS Q/Q
687.1%
-
-
-
-
SMA20
-
SMA50
12.5%
SMA100
12.5%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-4%
ROC
-0.02%
Gross Margin
8%
Oper. Margin
-6%
Profit Margin
-10%
Payout
-2%
Shs Outstand
441.28M
Shs Float
238.38M
-
-
-
-
Target Price
-
52W Range
6.18-13.52
52W High
-32.77%
52W Low
+45.67%
RSI
43
Rel Volume
0.56
Avg Volume
36.89M
Volume
20.69M
Perf Week
-9.15%
Perf Month
13.21%
Perf Quarter
-
Perf Half Y
1.39%
-
-
-
-
Beta
0.635
-
-
Volatility
0.53%, 0.55%
Prev Close
2.1%
Price
8.74
Change
-2.35%
002173.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.5 | 1.92 | 1.59 | 1.59 | 1.64 | |
Net income per share | 0.07 | -2.53 | -0.69 | -0.23 | -0.17 | |
Operating cash flow per share | 0.31 | 0.21 | 0.29 | 0.1 | -0.06 | |
Free cash flow per share | -0.64 | -0.14 | 0.05 | -0.15 | -0.34 | |
Cash per share | 1.46 | 2.07 | 2.07 | 1.78 | 1.52 | |
Book value per share | 8.53 | 5.43 | 4.71 | 4.44 | 4.39 | |
Tangible book value per share | 5.84 | 4.86 | 4.43 | 4.16 | 4.11 | |
Share holders equity per share | 8.53 | 5.43 | 4.71 | 4.44 | 4.39 | |
Interest debt per share | 0.93 | 0.25 | 0.15 | 0.16 | 0.14 | |
Market cap | 3.08B | 2.84B | 2.57B | 3.74B | 2.83B | |
Enterprise value | 2.87B | 2.05B | 2.28B | 3.58B | 2.23B | |
P/E ratio | 103.71 | -2.47 | -8.16 | -35.59 | -38.26 | |
Price to sales ratio | 2.91 | 3.25 | 3.54 | 5.26 | 3.98 | |
POCF ratio | 23.78 | 29.43 | 19.48 | 86.27 | -115.62 | |
PFCF ratio | -11.38 | -44.25 | 110.06 | -55.55 | -19.15 | |
P/B Ratio | 0.85 | 1.15 | 1.2 | 1.88 | 1.48 | |
PTB ratio | 0.85 | 1.15 | 1.2 | 1.88 | 1.48 | |
EV to sales | 2.71 | 2.35 | 3.15 | 5.03 | 3.14 | |
Enterprise value over EBITDA | 9.38 | -54.47 | -58.84 | 345.37 | 57.58 | |
EV to operating cash flow | 22.14 | 21.3 | 17.32 | 82.54 | -91.08 | |
EV to free cash flow | -10.6 | -32.03 | 97.84 | -53.15 | -15.08 | |
Earnings yield | 0.01 | -0.41 | -0.12 | -0.03 | -0.03 | |
Free cash flow yield | -0.09 | -0.02 | 0.01 | -0.02 | -0.05 | |
Debt to equity | 0.1 | 0.04 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.08 | 0.03 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | -0.69 | 20.79 | 7.35 | -15.62 | -15.52 | |
Current ratio | 3.62 | 3.89 | 3.12 | 2.72 | 2.39 | |
Interest coverage | 3.45 | -4.05 | -13.29 | -17.68 | -21.37 | |
Income quality | 4.32 | -0.08 | -0.42 | -0.41 | 0.33 | |
Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
Payout ratio | 2.17 | -0.01 | -0.01 | -0.02 | -0.01 | |
Sales general and administrative to revenue | 0.03 | 0.05 | 0.05 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.27 | 0.09 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -3.09 | -1.67 | -0.82 | -2.55 | 5.04 | |
Capex to revenue | -0.38 | -0.18 | -0.15 | -0.16 | -0.17 | |
Capex to depreciation | -4.22 | -1.54 | -0.97 | -0.94 | -1.12 | |
Stock based compensation to revenue | 0 | 0.02 | -0.03 | 0.01 | 0 | |
Graham number | 3.67 | 17.58 | 8.56 | 4.84 | 4.1 | |
ROIC | 0.01 | -0.03 | -0.05 | -0.05 | -0.04 | |
Return on tangible assets | 0.01 | -0.42 | -0.12 | -0.04 | -0.03 | |
Graham Net | 0.73 | 1.4 | 1.15 | 0.73 | 0.68 | |
Working capital | 1.25B | 911.87M | 761.56M | 594.05M | 449.28M | |
Tangible asset value | 2.48B | 2.21B | 2.02B | 1.86B | 1.78B | |
Net current asset value | 1.08B | 729.56M | 586.85M | 374.75M | 337.23M | |
Invested capital | 0.1 | 0.04 | 0.03 | 0.03 | 0.03 | |
Average receivables | 358.24M | 324.3M | 180.13M | 114.72M | 77.6M | |
Average payables | 93.37M | 133.11M | 173.55M | 181.92M | 196.72M | |
Average inventory | 388.93M | 51.16M | 44.02M | 38.76M | 46.15M | |
Days sales outstanding | 145.97 | 94.22 | 68.1 | 48.39 | 31.31 | |
Days payables outstanding | 54.46 | 75.73 | 94.59 | 100.59 | 112.91 | |
Days of inventory on hand | 26.67 | 24.34 | 18.07 | 23.61 | 26.47 | |
Receivables turnover | 2.5 | 3.87 | 5.36 | 7.54 | 11.66 | |
Payables turnover | 6.7 | 4.82 | 3.86 | 3.63 | 3.23 | |
Inventory turnover | 13.68 | 15 | 20.19 | 15.46 | 13.79 | |
ROE | 0.01 | -0.47 | -0.15 | -0.05 | -0.04 | |
Capex per share | -0.94 | -0.35 | -0.24 | -0.25 | -0.28 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.44 | 0.39 | 0.45 | 0.49 | 0.46 | |
Net income per share | 0.08 | -0.14 | 0 | 0 | -0.02 | |
Operating cash flow per share | 0.08 | -0.14 | 0 | 0.01 | 0.03 | |
Free cash flow per share | 0.02 | -0.21 | -0.05 | -0.04 | -0.03 | |
Cash per share | 1.37 | 1.53 | 1.43 | 1.37 | 1.33 | |
Book value per share | 4.29 | 4.43 | 4.23 | 4.6 | 4.28 | |
Tangible book value per share | 4.02 | 4.15 | 3.96 | 4.31 | 4.01 | |
Share holders equity per share | 4.29 | 4.43 | 4.23 | 4.6 | 4.28 | |
Interest debt per share | 0.12 | 0.14 | 0.12 | 0.07 | 0.14 | |
Market cap | 2.74B | 2.8B | 3.21B | 4.35B | 3.99B | |
Enterprise value | 2.16B | 2.2B | 2.62B | 3.78B | 3.43B | |
P/E ratio | 19.44 | -11.54 | -382.66 | -841.23 | -92.68 | |
Price to sales ratio | 13.36 | 16.58 | 15.71 | 21.65 | 19.76 | |
POCF ratio | 77.76 | -46.15 | -1.53K | 1.02K | 336.45 | |
PFCF ratio | 355.92 | -31.22 | -130.54 | -251.4 | -360.69 | |
P/B Ratio | 1.39 | 1.47 | 1.69 | 2.29 | 2.11 | |
PTB ratio | 1.39 | 1.47 | 1.69 | 2.29 | 2.11 | |
EV to sales | 10.54 | 13.03 | 12.83 | 18.8 | 16.99 | |
Enterprise value over EBITDA | 57.74 | -29.35 | -3.83K | 1.82K | -460.71 | |
EV to operating cash flow | 61.35 | -36.27 | -1.25K | 881.71 | 289.23 | |
EV to free cash flow | 280.83 | -24.53 | -106.59 | -218.32 | -310.07 | |
Earnings yield | 0.01 | -0.02 | 0 | 0 | 0 | |
Free cash flow yield | 0 | -0.03 | -0.01 | 0 | 0 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | |
Net debt to EBITDA | -15.44 | 7.99 | 859.46 | -275.81 | 75.21 | |
Current ratio | 2.93 | 2.39 | 2.46 | 2.62 | 2.43 | |
Interest coverage | 8.49 | -37.19 | -0.27 | -18.69 | -7.89 | |
Income quality | 1 | 1 | 1 | -3.31 | -1.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.01 | 0 | -0.19 | -0.33 | -0.03 | |
Sales general and administrative to revenue | 0.31 | -0.29 | 0.13 | -0.07 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.78 | 0.48 | 10.73 | -5.04 | -1.93 | |
Capex to revenue | -0.13 | -0.17 | -0.11 | -0.11 | -0.11 | |
Capex to depreciation | -0.95 | -1 | -0.82 | -0.79 | 0.46 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.72 | 3.75 | 0.67 | 0.57 | 1.53 | |
ROIC | 0 | -0.02 | 0 | 0 | -0.01 | |
Return on tangible assets | 0.02 | -0.03 | 0 | 0 | 0 | |
Graham Net | 0.79 | 0.68 | 0.67 | 0.69 | 0.62 | |
Working capital | 519.05M | 449.28M | 457.79M | 447.55M | 445.2M | |
Tangible asset value | 1.85B | 1.78B | 1.78B | 1.78B | 1.77B | |
Net current asset value | 414.67M | 337.23M | 347.07M | 364.67M | 357.03M | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | |
Average receivables | 122.7M | 87.73M | 69.82M | 79.78M | 87.08M | |
Average payables | 177.15M | 195.5M | 203.44M | 187.62M | 178.04M | |
Average inventory | 35.42M | 43.55M | 48.33M | 42.78M | 39.03M | |
Days sales outstanding | 50.31 | 32.4 | 34.71 | 36.16 | 41.63 | |
Days payables outstanding | 93.26 | 103.03 | 101.13 | 93.48 | 88.06 | |
Days of inventory on hand | 19.51 | 24.15 | 24.36 | 19.98 | 19.78 | |
Receivables turnover | 1.79 | 2.78 | 2.59 | 2.49 | 2.16 | |
Payables turnover | 0.97 | 0.87 | 0.89 | 0.96 | 1.02 | |
Inventory turnover | 4.61 | 3.73 | 3.69 | 4.5 | 4.55 | |
ROE | 0.02 | -0.03 | 0 | 0 | -0.01 | |
Capex per share | -0.06 | -0.07 | -0.05 | -0.05 | -0.05 |
002173.SZ Frequently Asked Questions
What is Innovation Medical Management Co., Ltd. stock symbol ?
Innovation Medical Management Co., Ltd. is a CN stock and trading under the symbol 002173.SZ
What is Innovation Medical Management Co., Ltd. stock quote today ?
Innovation Medical Management Co., Ltd. stock price is $8.74 today.
Is Innovation Medical Management Co., Ltd. stock public?
Yes, Innovation Medical Management Co., Ltd. is a publicly traded company.